Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McCarthy

Showing results (351-360 of 369) with videos related to

Pageof 37
Sort By:
Cancer Research|November 8, 2013
Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formationLaura R Bohrer, Pavlina Chuntova, Lindsey K Bade, et al.
Journal of the National Cancer Institute|September 21, 2010
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancerXinhui Wang, Takuya Osada, Yangyang Wang, et al.
Carcinogenesis|October 26, 2012
miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinomaZhaohui Luo, Yafei Dai, Liyang Zhang, et al.
Structure (London, England : 1993)|June 24, 2025
Targeting ceramide synthases for the development of new antifungalsDeveney Dasilva, Nivea Pereira de Sa, Kathryn Takemura, et al.
BMC Cancer|April 9, 2014
Evaluation of protein biomarkers of prostate cancer aggressivenessAnthony E Rizzardi, Nikolaus K Rosener, Joseph S Koopmeiners, et al.
Plos One|March 9, 2013
SPLUNC1 regulates cell progression and apoptosis through the miR-141-PTEN/p27 pathway, but is hindered by LMP1Pan Chen, Xiaofang Guo, Houde Zhou, et al.
Cell Reports|April 20, 2017
Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression LevelRebecca L Klank, Stacy A Decker Grunke, Benjamin L Bangasser, et al.
Cell Reports|January 5, 2017
Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression LevelRebecca L Klank, Stacy A Decker Grunke, Benjamin L Bangasser, et al.
Translational Oncology|December 23, 2021
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formationJianbo Yang, Qianjin Liao, Matthew Price, et al.
Cancer|March 27, 2014
Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumorsAnthony E Rizzardi, Rachel Isaksson Vogel, Joseph S Koopmeiners, et al.
Pageof 37

Showing results (351-360 of 369) with videos related to

Sort By:
Pageof 37
Cancer Research|November 8, 2013
Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formationLaura R Bohrer, Pavlina Chuntova, Lindsey K Bade, et al.
Journal of the National Cancer Institute|September 21, 2010
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancerXinhui Wang, Takuya Osada, Yangyang Wang, et al.
Carcinogenesis|October 26, 2012
miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinomaZhaohui Luo, Yafei Dai, Liyang Zhang, et al.
Structure (London, England : 1993)|June 24, 2025
Targeting ceramide synthases for the development of new antifungalsDeveney Dasilva, Nivea Pereira de Sa, Kathryn Takemura, et al.
BMC Cancer|April 9, 2014
Evaluation of protein biomarkers of prostate cancer aggressivenessAnthony E Rizzardi, Nikolaus K Rosener, Joseph S Koopmeiners, et al.
Plos One|March 9, 2013
SPLUNC1 regulates cell progression and apoptosis through the miR-141-PTEN/p27 pathway, but is hindered by LMP1Pan Chen, Xiaofang Guo, Houde Zhou, et al.
Cell Reports|April 20, 2017
Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression LevelRebecca L Klank, Stacy A Decker Grunke, Benjamin L Bangasser, et al.
Cell Reports|January 5, 2017
Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression LevelRebecca L Klank, Stacy A Decker Grunke, Benjamin L Bangasser, et al.
Translational Oncology|December 23, 2021
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formationJianbo Yang, Qianjin Liao, Matthew Price, et al.
Cancer|March 27, 2014
Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumorsAnthony E Rizzardi, Rachel Isaksson Vogel, Joseph S Koopmeiners, et al.
Pageof 37